Notizie GT Biopharma - GTBP

Ultime notizie

Data	Ora	Fonte	Titolo
17/6/2024	22:26	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
13/6/2024	22:14	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
07/6/2024	23:25	EDGAR2	Form 8-K - Current report
24/5/2024	02:31	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
23/5/2024	12:04	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
23/5/2024	12:02	EDGAR2	Form 8-K - Current report
15/5/2024	23:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/2/2024	20:46	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
01/2/2024	18:15	EDGAR2	Form 8-K - Current report
21/12/2023	21:30	EDGAR2	Form 8-K - Current report
04/12/2023	23:00	EDGAR2	Form 8-K - Current report
06/11/2023	23:25	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
06/11/2023	23:23	EDGAR2	Form DEFA14A - Additional definitive proxy soliciting..
06/11/2023	23:21	EDGAR2	Form DEF 14A - Other definitive proxy statements
01/11/2023	14:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
27/10/2023	23:23	EDGAR2	Form PRE 14A - Other preliminary proxy statements
19/9/2023	17:56	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
22/8/2023	22:55	EDGAR2	Form 8-K - Current report
16/8/2023	01:29	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
16/8/2023	01:26	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
07/8/2023	15:30	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05/7/2023	15:00	EDGAR2	Form 8-K - Current report

Apertura: 2,85	Min: 2,80	Max: 2,94
Chiusura: 2,85